Diabetes Mellitus

iStock

Guest article

Endocannabinoid claims, climate change, adulteration progress: What to look for in 2018

By Mark Blumenthal, founder and excutive director, American Botanical Council

Editor's note: Climate change, enthusiasm about the endocannabinoid system and the emergence of a Mexican blood sugar control ingredient are among the things that will characterize 2018 in the botanical industy, according to ABC founder Mark Blumenthal.

According to the World Health Organization (WHO), there are about 60 million people with diabetes in the European Region. ©iStock/

Personalised nutrition: Listening to the gut microbiome

By Will Chu from Amsterdam

Personalised diets may provide diabetics with a more natural way of controlling the post-meal spikes in blood sugar glucose that are linked to obesity, hypertension and cardiovascular disease, a study suggests. 

Typical EU-approved claims: “Consumption of [X] contributes to the reduction of the blood glucose rise after that meal [post-prandial].”

Special edition: Blood sugar management

Glycaemic (GI) foods remain in obesity-diabetes niche but claims are changing game

By Shane STARLING

Foods that help moderate blood sugar activity are gaining more traction with diabetics, the overweight and the obese – with new EU claims backing their promise to control hunger impulses. With 2bn people overweight or obese in the world, and type-2 diabetes...

Study: Big breakfast could help manage type 2 diabetes

Study: Big breakfast could help manage type 2 diabetes

By Maggie Hennessy

It’s no secret that incidence of being overweight and obese have increased dramatically over the past few decades alongside a rise in the prevalence of type 2 diabetes. Concurrent with this, eating breakfast has declined overall.

“Newer treatments are required to complement and enhance the efficacy of existing diabetic regimen,

Two studies hail resveratrol type 2 diabetes potential

By Annie-Rose Harrison-Dunn

Supplemental resveratrol should be considered as an adjunct to standard anti-diabetic agents in the treatment of type 2 diabetes, according to two studies conducted at the University of Medical Sciences in Iran and JSS University in India.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All